Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 200,000 shares at $61.50 ($12.3M) on 2017-02-21, disclosed to the SEC on 2017-02-23.
Open-market sale of $12.3M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.50 | 2,747 | $169K | 1.4% |
| 2 | $61.50 | 2,747 | $169K | 1.4% |
| 3 | $61.50 | 97,253 | $6.0M | 48.6% |
| 4 | $61.50 | 97,253 | $6.0M | 48.6% |
| Total | $61.50 avg | 200,000 | $12.3M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |